Asset Dedication’s Adaptive Biotechnologies ADPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$10.1K Hold
350
– – ﹤0.01% 793
2026
Q2
$7.51K Hold
350
– – ﹤0.01% 834
2026
Q1
$4.86K Hold
350
– – ﹤0.01% 864
2025
Q4
$5.68K Hold
350
– – ﹤0.01% 874
2025
Q3
$5.24K Hold
350
– – ﹤0.01% 897
2025
Q2
$4.08K Sell
350
-881
-72% -$8K ﹤0.01% 959
2025
Q1
$9.15K Hold
1,231
– – ﹤0.01% 774
2024
Q4
$7.38K Hold
1,231
– – ﹤0.01% 804
2024
Q3
$6.3K Hold
1,231
– – ﹤0.01% 868
2024
Q2
$4.46K Hold
1,231
– – ﹤0.01% 944
2024
Q1
$4K Hold
1,231
– – ﹤0.01% 802
2023
Q4
$6K Sell
1,231
-67
-5% -$306 ﹤0.01% 748
2023
Q3
$7K Hold
1,298
– – ﹤0.01% 723
2023
Q2
$8K Buy
1,298
+67
+5% +$498 ﹤0.01% 690
2023
Q1
$11K Hold
1,231
– – ﹤0.01% 647
2022
Q4
$9K Hold
1,231
– – ﹤0.01% 665
2022
Q3
$8K Hold
1,231
– – ﹤0.01% 652
2022
Q2
$10K Hold
1,231
– – ﹤0.01% 344
2022
Q1
$17K Hold
1,231
– – ﹤0.01% 578
2021
Q4
$35K Hold
1,231
– – ﹤0.01% 462
2021
Q3
$42K Hold
1,231
– – 0.01% 440
2021
Q2
$51K Buy
1,231
+1,001
+435% +$38.9K 0.01% 390
2021
Q1
$10K Sell
230
-120
-34% -$6.5K ﹤0.01% 500
2020
Q4
$21K Hold
350
– – ﹤0.01% 455
2020
Q3
$17K Buy
350
+195
+126% +$8.2K ﹤0.01% 463
2020
Q2
$7K Buy
+155
New +$5.65K ﹤0.01% 491

Other funds holding ADPT

Asset Dedication's ADPT Position: Q3 2026 in Review

Asset Dedication held its Adaptive Biotechnologies (ADPT) position steady in Q3 2026 at 350 shares worth $10.1K. The position accounts for ﹤0.01% of the portfolio, ranked #793.

Asset Dedication first reported a position in ADPT in Q2 2020 and has held it in 26 quarters since. The position peaked at $51K in Q2 2021. 244 funds tracked by Wall St. Rank hold ADPT as of Q3 2026.

  • Asset Dedication held 350 shares of Adaptive Biotechnologies worth $10.1K as of Q3 2026.
  • Asset Dedication left its Adaptive Biotechnologies share count unchanged in Q3 2026.
  • Adaptive Biotechnologies made up ﹤0.01% of Asset Dedication's portfolio in Q3 2026, its #793 holding.
  • Asset Dedication first reported a position in Adaptive Biotechnologies in Q2 2020 and has held it in 26 quarters since.
  • Asset Dedication's Adaptive Biotechnologies position peaked at $51K in Q2 2021.
  • 244 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q3 2026.

Based on Asset Dedication's 13F filing for Q3 2026, filed 3 Nov 2026.